Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
SCRAJ-STT204 | Human | Raji/Membrane-Bound Human TL1A Stable Cell Line Development Service | |||
CHEK-ATP198 | Human | HEK293/Membrane-Bound human TL1A Stable Cell Line | |||
TLA-H5246 | Human | Human TL1A / TNFSF15 Protein, His Tag (Monomer) (MALS verified) |
|
||
CHEK-ATP142 | Human | HEK293/Human TL1A Stable Cell Line | |||
TLA-R5249 | Rat | Rat TL1A Protein, His Tag |
|
||
TLA-H5245 | Human | Human TL1A / TNFSF15 Protein, His Tag |
|
||
TLA-M5243 | Mouse | Mouse TL1A Protein, His Tag (HPLC-verified) |
|
||
TLA-H5244 | Human | Human TL1A / TNFSF15 Protein, His Tag |
|
||
TLA-H52Q1 | Human | Biotinylated Human TL1A / TNFSF15 Protein, His,Avitag™ |
|
||
TLA-C5241 | Cynomolgus / Rhesus macaque | Cynomolgus/Rhesus macaque TL1A / TNFSF15 Protein, His Tag |
|
||
TLA-H5243 | Human | Human TL1A / TNFSF15 Protein, His Tag, active trimer (MALS verified) |
|
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tulisokibart | MK-7240; PRA023; PRA-023 | Phase 3 Clinical | Prometheus Biosciences Inc, Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Colitis, Ulcerative; Scleroderma, Diffuse; Crohn Disease | Details |
TEV-48574 | TEV-48574; TEV-574; TEV574 | Phase 2 Clinical | Teva Pharmaceutical Industries Ltd | Colitis, Ulcerative; Asthma; Crohn Disease | Details |
RVT-3101 | PF-06480605; PF 6480605; RVT-3101 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease | Details |
Next-generation anti-TL1A antibody(Telavant) | Phase 1 Clinical | Telavant Inc | Fibrosis; Inflammation | Details | |
Tulisokibart | MK-7240; PRA023; PRA-023 | Phase 3 Clinical | Prometheus Biosciences Inc, Merck Sharp & Dohme LLC | Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Colitis, Ulcerative; Scleroderma, Diffuse; Crohn Disease | Details |
TEV-48574 | TEV-48574; TEV-574; TEV574 | Phase 2 Clinical | Teva Pharmaceutical Industries Ltd | Colitis, Ulcerative; Asthma; Crohn Disease | Details |
RVT-3101 | PF-06480605; PF 6480605; RVT-3101 | Phase 2 Clinical | Pfizer Inc | Inflammatory Bowel Diseases; Colitis, Ulcerative; Crohn Disease | Details |
Next-generation anti-TL1A antibody(Telavant) | Phase 1 Clinical | Telavant Inc | Fibrosis; Inflammation | Details |
This web search service is supported by Google Inc.